The dosage of curcumin from each supplement type was not equal.
Theracurmin containing 90 mg of curcumin.
30 mg providing a controlled surface the colloidal dispersion 30 mg of curcumin turmeric root extract daily value not established other ingredients.
Individuals were asked not to consume curcumin containing food for more than 7 days prior to the study.
Attention was assessed as a secondary outcome.
6 capsules equivalent to 180 mg curcumin.
The experimental group took theracurmin containing 90 mg of curcumin twice daily i e 180 mg curcumin day for 18 months.
This same dose was used in a successful trial of patients with mild cognitive impairment.
The experimental group took theracurmin containing 90 mg of curcumin twice a day ie 180 mg curcumin day for 18 months.
Theracurmin is a novel preparation of turmeric that utilizes patented colloidal dispersion technology to enhance bioavailability and dramatically increase curcumin levels in the blood unlike other forms of curcumin theracurmin is water dispersible meaning it dissolves quickly and maintains solubility over time thereby improving curcumin s overall absorption.
Verbal performance buschke selective reminding test srt visual performance brief visual memory test revised bvmt r.
The intervention is twice daily dosage of theracurmin 90 mg capsules.
Subjects will be randomly assigned to one of two treatment groups.
1 capsule equivalent to 260 mg.
The following tests were used to assess cognitive performance.
Cognitive performance was assessed through verbal and visual testing.
Primary outcomes were verbal buschke selective reminding test srt and visual brief visual memory test revised bvmt r memory and attention trail making a was a secondary outcome.
The investigators expect that the volunteers receiving the curcumin supplement will show less evidence of decline after 18 months than those receiving the placebo.
Blood samples were collected at regular intervals.
Microcrystalline cellulose vegetable capsule carbohydrate gum cellulose purified water magnesium stearate vegetable grade silica.
The study lasted for 3 weeks.
Forty subjects age 51 84 years were randomized to a bioavailable form of curcumin theracurmin containing 90 mg of curcumin twice daily n 21 or placebo n 19 for 18 months.